# OnCo record paper-aspen-armstrong-lancet-oncol-2016 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-aspen-armstrong-lancet-oncol-2016/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-aspen-armstrong-lancet-oncol-2016" ;
  schema:name "ASPEN: everolimus versus sunitinib in metastatic non-clear cell renal cell carcinoma"@en ;
  schema:description "In the first randomised trial dedicated to non-clear cell kidney cancers, sunitinib delayed progression more than everolimus overall, though chromophobe tumours appeared to fare better on everolimus."@en ;
  schema:url <https://onco.cc/key-papers/paper-aspen-armstrong-lancet-oncol-2016/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(15)00515-X>, <https://pubmed.ncbi.nlm.nih.gov/26794930/> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(15)00515-X> ;
  schema:datePublished "2016"^^xsd:gYear ;
  schema:author "Armstrong AJ, Halabi S, Eisen T, et al." ;
  onco:cancers <https://onco.cc/cancers/chromophobe-rcc/>, <https://onco.cc/cancers/papillary-rcc/> ;
  onco:drugs <https://onco.cc/drugs/everolimus/>, <https://onco.cc/drugs/sunitinib/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .